Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,294,939
-
Total 13F shares
-
33,411,564
-
Share change
-
+1,691,467
-
Total reported value
-
$3,197,551,286
-
Put/Call ratio
-
150%
-
Price per share
-
$95.76
-
Number of holders
-
265
-
Value change
-
+$129,661,774
-
Number of buys
-
140
-
Number of sells
-
123
Institutional Holders of CONMED Corp - Common Stock (CNMD) as of Q2 2022
As of 30 Jun 2022,
CONMED Corp - Common Stock (CNMD) was held by
265 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,411,564 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, EARNEST PARTNERS LLC, Capital Research Global Investors, Champlain Investment Partners, LLC, AMERIPRISE FINANCIAL INC, STATE STREET CORP, JPMORGAN CHASE & CO, Invesco Ltd., and BANK OF AMERICA CORP /DE/.
This page lists
266
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.